Enhabit (EHAB) Stock Forecast, Price Target & Predictions
EHAB Stock Forecast
Enhabit stock forecast is as follows: an average price target of $9.50 (represents a 13.10% upside from EHAB’s last price of $8.40) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.
EHAB Price Target
EHAB Analyst Ratings
Hold
Enhabit Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Dec 09, 2024 | Brian Tanquilut | Jefferies | $9.50 | $7.73 | 22.90% | 13.10% |
May 14, 2024 | Whit Mayo | Leerink Partners | $8.50 | $8.64 | -1.62% | 1.19% |
Dec 08, 2022 | UBS | $12.00 | $13.99 | -14.22% | 42.86% |
Enhabit Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 2 |
Avg Price Target | - | $9.50 | $9.00 |
Last Closing Price | $8.40 | $8.40 | $8.40 |
Upside/Downside | -100.00% | 13.10% | 7.14% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
May 14, 2024 | Leerink Partners | Market Perform | Upgrade | |
May 09, 2024 | Jefferies | Hold | Downgrade | |
Mar 07, 2024 | UBS | Sell | Neutral | Upgrade |
Aug 11, 2023 | Credit Suisse | Neutral | Neutral | Hold |
Dec 13, 2022 | CJS Securities | Market Perform | Initialise | |
Dec 08, 2022 | UBS | Sell | Initialise | |
Oct 13, 2022 | Oppenheimer | Perform | Initialise |
Enhabit Financial Forecast
Enhabit Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $260.60M | $258.30M | - | $265.10M | $275.10M | $265.70M | $268.00M |
Avg Forecast | $282.72M | $284.16M | $272.58M | $271.65M | $273.29M | $269.23M | $266.83M | $267.04M | $259.11M | $261.60M | $267.33M | $268.45M | $260.16M | $265.32M | $273.51M | $271.45M | $267.86M | $266.45M | $268.18M |
High Forecast | $291.00M | $292.48M | $280.56M | $279.60M | $281.30M | $277.12M | $274.64M | $274.96M | $262.84M | $262.09M | $267.33M | $268.45M | $263.76M | $265.39M | $281.52M | $279.40M | $274.94M | $266.45M | $268.18M |
Low Forecast | $272.65M | $274.03M | $262.87M | $261.97M | $263.56M | $259.64M | $257.32M | $259.12M | $255.66M | $261.11M | $267.33M | $268.45M | $257.29M | $265.26M | $263.77M | $261.78M | $259.77M | $266.45M | $268.18M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.97% | - | 0.98% | 1.03% | 1.00% | 1.00% |
Forecast
Enhabit EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $12.60M | $15.60M | - | $22.00M | $36.80M | $25.90M | $35.50M |
Avg Forecast | $22.55M | $22.67M | $21.75M | $21.67M | $21.80M | $21.48M | $21.29M | $21.30M | $20.67M | $20.87M | $21.33M | $21.42M | $20.75M | $21.17M | $21.82M | $21.66M | $21.37M | $31.50M | $163.30M |
High Forecast | $23.22M | $23.33M | $22.38M | $22.31M | $22.44M | $22.11M | $21.91M | $21.94M | $20.97M | $20.91M | $21.33M | $21.42M | $21.04M | $21.17M | $22.46M | $22.29M | $21.93M | $31.50M | $195.96M |
Low Forecast | $21.75M | $21.86M | $20.97M | $20.90M | $21.03M | $20.71M | $20.53M | $20.67M | $20.40M | $20.83M | $21.33M | $21.42M | $20.53M | $21.16M | $21.04M | $20.88M | $20.72M | $31.50M | $130.64M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.61% | 0.74% | - | 1.02% | 1.72% | 0.82% | 0.22% |
Forecast
Enhabit Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-6.40M | $-2.40M | - | $2.70M | $7.70M | $8.60M | $20.10M |
Avg Forecast | $4.06M | $5.63M | $4.70M | $4.39M | $3.68M | $2.74M | $3.48M | $3.54M | $2.72M | $1.97M | $2.86M | $2.33M | $1.27M | $3.05M | $6.77M | $7.72M | $11.67M | $14.50M | $20.92M |
High Forecast | $4.21M | $5.85M | $4.88M | $4.56M | $3.82M | $2.84M | $3.61M | $3.67M | $3.81M | $2.04M | $2.86M | $2.34M | $1.29M | $3.17M | $7.03M | $8.01M | $12.08M | $14.50M | $25.10M |
Low Forecast | $3.87M | $5.37M | $4.48M | $4.19M | $3.51M | $2.61M | $3.32M | $2.95M | $2.18M | $1.88M | $2.86M | $2.32M | $1.25M | $2.91M | $6.45M | $7.36M | $11.22M | $14.50M | $16.74M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -5.06% | -0.79% | - | 0.35% | 0.66% | 0.59% | 0.96% |
Forecast
Enhabit SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $114.50M | $108.80M | - | $110.50M | $106.50M | $107.50M | $102.20M |
Avg Forecast | $111.71M | $112.28M | $107.71M | $107.34M | $107.99M | $106.38M | $105.43M | $105.52M | $102.39M | $103.37M | $105.63M | $106.07M | $102.80M | $104.84M | $108.08M | $107.26M | $105.84M | $105.29M | $106.37M |
High Forecast | $114.99M | $115.57M | $110.86M | $110.48M | $111.15M | $109.50M | $108.52M | $108.65M | $103.86M | $103.56M | $105.63M | $106.07M | $104.22M | $104.87M | $111.24M | $110.40M | $108.64M | $105.29M | $127.65M |
Low Forecast | $107.74M | $108.28M | $103.87M | $103.51M | $104.14M | $102.59M | $101.68M | $102.39M | $101.02M | $103.17M | $105.63M | $106.07M | $101.67M | $104.81M | $104.23M | $103.44M | $102.64M | $105.29M | $85.10M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 1.04% | - | 1.03% | 1.01% | 1.02% | 0.96% |
Forecast
Enhabit EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.13 | $-0.05 | - | $0.05 | $0.15 | $0.17 | $0.41 |
Avg Forecast | $0.08 | $0.11 | $0.09 | $0.09 | $0.07 | $0.05 | $0.07 | $0.07 | $0.05 | $0.04 | $0.06 | $0.05 | $0.03 | $0.06 | $0.13 | $0.15 | $0.23 | $0.29 | $0.49 |
High Forecast | $0.08 | $0.12 | $0.10 | $0.09 | $0.08 | $0.06 | $0.07 | $0.07 | $0.08 | $0.04 | $0.06 | $0.05 | $0.03 | $0.06 | $0.14 | $0.16 | $0.24 | $0.29 | $0.49 |
Low Forecast | $0.08 | $0.11 | $0.09 | $0.08 | $0.07 | $0.05 | $0.07 | $0.06 | $0.04 | $0.04 | $0.06 | $0.05 | $0.02 | $0.06 | $0.13 | $0.15 | $0.22 | $0.29 | $0.49 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -5.15% | -0.79% | - | 0.33% | 0.65% | 0.59% | 0.84% |
Forecast
Enhabit Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
SEM | Select Medical | $19.60 | $40.00 | 104.08% | Buy |
ACHC | Acadia Healthcare | $43.74 | $81.50 | 86.33% | Buy |
INNV | InnovAge | $3.73 | $6.80 | 82.31% | Hold |
HCSG | Healthcare Services Group | $11.36 | $17.33 | 52.55% | Hold |
PNTG | Pennant Group | $27.51 | $34.67 | 26.03% | Buy |
ENSG | Ensign Group | $140.58 | $167.33 | 19.03% | Buy |
ADUS | Addus HomeCare | $126.27 | $146.20 | 15.78% | Buy |
EHAB | Enhabit | $8.40 | $9.50 | 13.10% | Hold |
EHC | Encompass Health | $95.57 | $107.50 | 12.48% | Buy |